Patients are hearing that Spiriva (tiotropium) might increase the risk of stroke

April 2008

Patients are hearing that Spiriva (tiotropium) might increase the risk of stroke.

A recent analysis shows a slightly higher risk of stroke in patients using Spiriva...or about 2 more cases per 1000 patients per year.

This is a surprise. So far there's no reason to suspect a link between inhaled anticholinergics and stroke.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote